These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 14339193)

  • 1. [HEADACHES AND THE SIGNIFICANCE OF LYSERGIC ACID DERIVATIVES IN THEIR TREATMENT].
    SZCZUDLOWSKI K; KUCZEWSKA K
    Pol Tyg Lek; 1965 Feb; 20():215-7. PubMed ID: 14339193
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical observations with 1-methyl-lysergic acid butanolamide (UML-491) in vascular headache.
    FRIEDMAN AP
    Angiology; 1960 Aug; 11():364-6. PubMed ID: 13825096
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of UML-491 in the treatment of vascular headaches. An analysis of the effects of 1-methyl-D-lysergic acid (plus) butanolamide bimaleate (methysergide).
    FRIEDMAN AP; LOSIN S
    Arch Neurol; 1961 Mar; 4():241-5. PubMed ID: 13701987
    [No Abstract]   [Full Text] [Related]  

  • 4. LYSERGIC ACID DIETHYL AMIDE (LSD-25): XXXVII. ANTISEROTONIN ACTION OF LYSERGIC ACID DERIVATIVES IN ALLERGY AND NEUROPSYCHIATRY.
    ABRAMSON HA
    J Asthma Res; 1965 Mar; 2(3):257-62. PubMed ID: 14285481
    [No Abstract]   [Full Text] [Related]  

  • 5. CENTRAL MECHANISMS IN HEADACHE.
    DALESSIO DJ
    Headache; 1965 Jan; 5():276-8. PubMed ID: 14264176
    [No Abstract]   [Full Text] [Related]  

  • 6. PROPHYLACTIC TREATMENT OF MIGRAINE BY MEANS OF LYSERGIC ACID DERIVATIVES.
    SICUTERI F
    Triangle; 1963 Oct; 6():116-25. PubMed ID: 14087164
    [No Abstract]   [Full Text] [Related]  

  • 7. [METHYSERGIDE. A NEW ATISEROTONIN COMPOUND IN THE TREATMENT OF HEADACHES].
    MOSOVICH A; SCORNIK JS; ALONSO E
    Prensa Med Argent; 1965 Mar; 52():352-6. PubMed ID: 14330150
    [No Abstract]   [Full Text] [Related]  

  • 8. Prophylaxis of frequent vascular headache with methysergide.
    HALE AR; REED AF
    Am J Med Sci; 1962 Jan; 243():92-8. PubMed ID: 13903795
    [No Abstract]   [Full Text] [Related]  

  • 9. CLINICAL STUDIES ON THE TREATMENT OF VASCULAR HEADACHES, A PROGRESS REPORT ON METHYSERGIDE (SANSERT).
    ABBOTT KH
    Headache; 1965 Jan; 5():261-71. PubMed ID: 14264174
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies in headache: further analysis of the mode of action of UML-491 and its relevance to the nature of vascular headache of the migraine type.
    DALESSIO DJ; CAMP WA; GOODELL H; WOLFF HG
    Trans Am Neurol Assoc; 1961; 86():95-8. PubMed ID: 13883198
    [No Abstract]   [Full Text] [Related]  

  • 11. TREATMENT OF HEADACHES IN CHILDREN.
    LIVINGSTON S; WHITEHOUSE D
    Mod Treat; 1964 Nov; 1():1391-8. PubMed ID: 14221289
    [No Abstract]   [Full Text] [Related]  

  • 12. Vasodilating headache: a suggested classification and results of prophylactic treatment with UML 491 (methysergide).
    ROOKE ED; RUSHTON JG; PETERS GA
    Proc Staff Meet Mayo Clin; 1962 Aug; 37():433-43. PubMed ID: 14493709
    [No Abstract]   [Full Text] [Related]  

  • 13. [PHARMACODYNAMIC ANTAGONISM BETWEEN 1-METHYL DERIVATIVE OF LYSERGIC ACID (DESERIL) AND 5-HYDROXYTRYPTAMINE (SEROTONIN) AND THEIR POSSIBLE REFLECTIONS IN OBSTETRIC THERAPY].
    MORLUNGHI C
    Minerva Ginecol; 1964 Nov; 16():938-41. PubMed ID: 14258966
    [No Abstract]   [Full Text] [Related]  

  • 14. [MEDICAL HEADACHES].
    SICUTERI F; FRANCHI G
    Aggiorn Clinico Ter; 1964 Mar; 5():1-70. PubMed ID: 14168418
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of the treatment of headache with Deseril].
    BRZECKI A
    Pol Tyg Lek; 1962 Mar; 17():440-2. PubMed ID: 13874157
    [No Abstract]   [Full Text] [Related]  

  • 16. [Blocking of the action of tryptaminic substances on smooth musculature by 1-methyl-lysergic acid butanolamide: UML 491].
    SOLLERO L; KURTZ GS
    Hospital (Rio J); 1962 Jul; 62():1-11. PubMed ID: 13914968
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic possibilities in idiopathic headaches. Analysis of about 1000 cases].
    Nattero G; Agostoni A; Brandi G; Cottino A; Gai V; Gastaldi L; Lisino F
    Minerva Med; 1976 Jun; 67(31):1999-2006. PubMed ID: 934545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [1-METHYL-LYSERGIC ACID BUTANOLAMIDE AND ADRENOCORTICAL ACTIVATION BY RESERPINE].
    PREZIOSI P; MANCA P; PASSARELLI E
    Med Pharmacol Exp Int J Exp Med; 1965; 12():43-8. PubMed ID: 14281476
    [No Abstract]   [Full Text] [Related]  

  • 19. [EFFECTS OF THYROTROPIC HORMONE AND 1-METHYL-LYSERGIC ACID BUTANOLAMIDE (UML) ON THYROID INHIBITION BY 5-HYDROXYTRYPTAMINE (5-HT))].
    D ADDABBO A; FANFANI G
    Folia Endocrinol; 1964 Oct; 17():658-65. PubMed ID: 14269516
    [No Abstract]   [Full Text] [Related]  

  • 20. POSSIBLE RENAL COMPLICATIONS OF SANSERT (METHYSERGIDE) THERAPY FOR HEADACHE.
    GRAHAM JR
    Headache; 1965 Apr; 5():12-4. PubMed ID: 14289772
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.